> top > docs > PMC:7195088 > spans > 6002-6406 > annotations

PMC:7195088 / 6002-6406 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
156 139-147 Species denotes patients Tax:9606
192 87-97 Chemical denotes remdesivir MESH:C000606551
193 307-318 Chemical denotes favipiravir MESH:C462182
194 323-333 Chemical denotes umifenovir MESH:C086979
216 130-138 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T25 130-138 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T21 87-97 Chemical denotes remdesivir http://purl.obolibrary.org/obo/CHEBI_145994
T22 307-318 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T23 323-333 Chemical denotes umifenovir http://purl.obolibrary.org/obo/CHEBI_134730

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T43 44-266 Sentence denotes Although promising in preclinical studies, remdesivir should be currently provided to COVID-19 patients only within RCT (preferentially) or compassionate-use/expanded-access programmes, owing to its investigational nature.